Source: The Pharma Letter

Sharp Edge: Sharp Edge Labs gains rights to compound library

USA-based privately-held drug developer Sharp Edge Labs has entered into a drug discovery collaboration...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Scott F Sneddon's photo - President & CEO of Sharp Edge

President & CEO

Scott F Sneddon

CEO Approval Rating

83/100

Read more